PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Orforglipron
Related studies linked through entity extraction aliases.
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- Status
- RECRUITING
- Phase
- PHASE3
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
- Status
- COMPLETED
- Phase
- PHASE1
A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- Status
- RECRUITING
- Phase
- PHASE3
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Status
- RECRUITING
- Phase
- PHASE3
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3